Company / Current Liabilities per Share
BIOCRYST PHARMACEUTICALS INC Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.90
FY2025
5-year range
$0.57 / $0.90
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#119 of 210
Health Care
What the data says
At $0.90, BIOCRYST PHARMACEUTICALS INC's current liabilities per share ranks #92 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.57 in FY2022 to $1.01 in FY2017.
Based on SEC 10-K filings.
0.90 in FY2025 with a 5-year CAGR of +7.3%.
Increased from $0.78 to $0.90 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +16.5%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Sector benchmark
-94.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 15.6% year-over-year.
- Ranks #119 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.90 | +15.6% |
| FY2024 | $0.78 | -0.6% |
| FY2023 | $0.78 | +37.5% |
| FY2022 | $0.57 | -2.0% |
| FY2021 | $0.58 | -8.3% |
| FY2020 | $0.63 | -20.9% |
| FY2019 | $0.80 | +18.6% |
| FY2018 | $0.67 | -33.6% |
| FY2017 | $1.01 | +36.9% |
| FY2016 | $0.74 | -14.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026